Efficacy of Switch to Lopinavir/Ritonavir in Improving Cognitive function in Efavirenz treated patients.
Phase of Trial: Phase IV
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Efavirenz
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms SLICE
- 21 May 2015 Status changed from completed to active, recruiting as per ISRCTN record.
- 31 Mar 2015 Status changed from active, no longer recruiting to completed, according to ISRCTN: Current Controlled Trials
- 13 Nov 2014 Status changed from recruiting to active, no longer recruiting. as reported by United Kingdom Clinical Research Network record.